Taking from the poor

first_imgRELATED ARTICLESMORE FROM AUTHOR WATCH: “Everyone is fighting so hard to get on” – Pat Ryan on competitive camogie squads Limerick Ladies National Football League opener to be streamed live Email Print Facebook  LIMERICK TD Willie O’Dea has slammed Tánaiste Joan Burton and her party’s management of social protection, as he reveals that research conducted by Labour proves that Budget 2015 benefited the wealthy more than those on lower incomes or welfare.According to Deputy O’Dea, the research showed that the distributive impact of Budget 2015 was uneven, with higher than average gains for the better-off.Sign up for the weekly Limerick Post newsletter Sign Up The most vulnerable 20 per cent saw the smallest improvements.The Fianna Fáil spokesperson on Social Protection commented: “This is further evidence of the absolute failure of the Labour Party in Government. Only three weeks ago we learned that Ireland’s deprivation rate had increased to a record of 30.5 per cent, and that almost one in eight children now live in consistent poverty. Now it’s emerged that when an opportunity arose in Budget 2015 to address this crisis, Labour opted to favour the better off when allocating state resources.”Deputy O’Dea lashed out at Tánaiste Joan Burton, saying that she “has presided over approximately €1.8 billion in cuts to social programmes”, which he claims has resulted in more than a million people experiencing “enforced deprivation” in 2013.The Limerick City TD concluded: “The number of long term unemployed has remained static at 180,000 for the past three years, while 74,000 young people are still out or work and not in any education or training schemes. These figures are a direct result of Labour’s policies in Government. This is their legacy. Labour in Government has slashed the very supports which aim to protect vulnerable people.” Previous articledREA up for debut of the year awardNext articleKiller appeals Limerick murder conviction John Keoghhttp://www.limerickpost.ie WhatsApp Advertisementcenter_img Predictions on the future of learning discussed at Limerick Lifelong Learning Festival Limerick Artist ‘Willzee’ releases new Music Video – “A Dream of Peace” Vanishing Ireland podcast documenting interviews with people over 70’s, looking for volunteers to share their stories Limerick’s National Camogie League double header to be streamed live NewsTaking from the poorBy John Keogh – February 6, 2015 718 Linkedin TAGSFianna FáilJoan BurtonLabourlimerickpoliticsWillie O’Dea Twitterlast_img read more

WHO sees ‘potentially positive data’ in treating coronavirus

first_imgThe World Health Organization said on Tuesday that some treatments appear to be limiting the severity or length of the COVID-19 disease and that it was focusing on learning more about four or five of the most promising ones.The Geneva-based WHO is leading a global initiative to develop safe and effective vaccines, tests and drugs to prevent, diagnose and treat COVID-19. The respiratory illness has infected 4.19 million people around the world, according to a Reuters tally.”We do have some treatments that seem to be in very early studies limiting the severity or the length of the illness but we do not have anything that can kill or stop the virus,” spokeswoman Margaret Harris told a briefing, referring to the body’s so-called Solidarity Trial of drugs against the disease. Topics : The trial, which involved 127 patients, compared those given the combination drug, made up of the HIV medicine lopinavir-ritonavir, the hepatitis drug ribavirin, and the multiple sclerosis treatment interferon beta, with a control group given just the HIV drug.A malaria treatment championed by US President Donald Trump as a “game changer” in the fight against the coronavirus again failed to show a benefit in patients hospitalized with COVID-19, a study this month found.While the study had certain limitations, doctors reported that the use of hydroxycholoquine neither lessened the need for patients requiring breathing assistance nor the risk of death.In Geneva, the WHO official sounded a note of caution around expectations for a vaccine, saying coronaviruses in general are “very tricky viruses” that are “difficult to produce vaccines against”.More than 100 potential COVID-19 vaccines are being developed, including several in clinical trials. The WHO said in April a vaccine would take at least 12 months.Harris said that the Americas were the current “center” of the pandemic, although she also noted rising cases in Africa. However, she said the continent had a “big advantage” over other countries with little experience of infectious disease outbreaks.”They often have very good contact tracing infrastructure and a deep, deep, deep memory and understanding of why we take a new pathogen very, very seriously,” she said, singling out South Africa for its effective testing and contact tracing.Asked about the reasons for high case loads in the United States and Brazil, Harris said: “Around the world we have seen that the warnings we put out right from the start, very, very early on, were not seen as warnings about a very serious, lethal disease.”She restated that the WHO, which has come under criticism especially from the United States for its handling of the pandemic, would conduct an “after-action” review that would include a “free and frank” discussion on its performance.US President Donald Trump is working to reopen the economy quickly against recommendations from health experts to move cautiously to avoid a resurgence of the virus that has so far killed more than 80,000 people in the United States, the highest death toll in the world. He said he acted early to prevent the spread of the disease.Brazil has registered a total of 168,331 confirmed cases of the virus and 11,519 deaths, the most deadly outbreak in an emerging market nation.center_img “We do have potentially positive data coming out but we need to see more data to be 100% confident that we can say this treatment over that one,” she added, saying more research was needed and planned.Harris did not name the treatments. Gilead Science Inc says its antiviral drug remdesivir has helped improve outcomes for COVID-19 patients.Clinical data released last month on remdesivir raised hopes it might be an effective treatment. Several studies looking at combinations of antiviral medicines have also suggested they may help patients fight off the virus.Results of a trial in Hong Kong released this month showed a triple drug combination of antiviral medicines helped relieve symptoms in patients with mild to moderate COVID-19 infection and swiftly reduced the amount of virus in their bodies.last_img read more